Modified-release magnesium attenuates premenstrual symptoms

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1574, 2007-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pilot Study of the Efficacy and Safety of a Modified-Release Magnesium 250mg Tablet (Sincromag ® ) for the Treatment of Premenstrual Syndrome

By Quaranta S.  

Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. : 51-58

Adis International

Access to resources Recommend Favorite

Fabrication and evaluation of captopril modified-release oral formulation

By Gohel Mukesh   Nagori Stavan Arunkumar  

Pharmaceutical Development and Technology, Vol. 14, Iss. 6, 2009-12 ,pp. : 679-686

Informa Healthcare

Access to resources Recommend Favorite

Mesalazine: modified-release superior to standard in UC

By  

Inpharma, Vol. 1, Iss. 1513, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Indiplon: Indiplon modified-release, Indiplon MR, NBI 34060, NBI 34060 modified-release, NBI 34060 MR

By  

Drugs in R&D, Vol. 3, Iss. 3, 2002-01 ,pp. : 197-199

Adis International

Access to resources Recommend Favorite

Modified-Release Nifedipine: A Review of the Use of Modified-Release Formulations in the Treatment of Hypertension and Angina Pectoris

By Croom Katherine F.   Wellington Keri  

Drugs, Vol. 66, Iss. 4, 2006-01 ,pp. : 497-528

Adis International

Access to resources Recommend Favorite